Researchers at the Wistar Institute and Emory University examined why therapeutic vaccines often fail to provide adequate results. Their preclinical studies suggest that T cells in chronically infected
During a recent UK study the experimental drug GDNF was administered to five Parkinson’s patients directly into the brain area suffering damage. Within a couple of months, patients
A total of 13 papers researching asthma in Australian populations are due to be published, providing an alarming insight into asthma among older generations. One South Australian study
The money forms part of the ‘Grand Challenges in Global Health’ initiative and is aimed at helping those in the developing world. The research grant is a share
This product is the first tentatively approved generic version of Sustiva tablets. The drug will now be available for purchase under the President Bush’s Emergency Plan for AIDS
Epix made the submissions after the FDA requested back in January that the company supply additional clinical information in support of a new drug application in magnetic resonance
The reports come a few days after the company revealed that it was launching five new vaccines by the year 2010. Now it seems the company is looking
Duramed is planning to implement StayinFront’s data analysis and decision support tool, Analytics, and its Pharma customer relationship management (CRM) platform to drive its sales force effectiveness and
The drug combines pioglitazone HCl and glimepiride, a sulfonylurea, to directly target insulin resistance, a condition in which the body does not efficiently use the insulin it produces.
The phase III trial known as “Encore” enrolled 510 patients with evidence of active inflammation. The data showed that Tysabri (natalizumab) helped decrease disease activity and promote remission.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.